MXPA03009484A - Agente preventivo/de remedio para enfermedades inflamatorias en la mucosa de la cavidad oral y lo similar. - Google Patents

Agente preventivo/de remedio para enfermedades inflamatorias en la mucosa de la cavidad oral y lo similar.

Info

Publication number
MXPA03009484A
MXPA03009484A MXPA03009484A MXPA03009484A MXPA03009484A MX PA03009484 A MXPA03009484 A MX PA03009484A MX PA03009484 A MXPA03009484 A MX PA03009484A MX PA03009484 A MXPA03009484 A MX PA03009484A MX PA03009484 A MXPA03009484 A MX PA03009484A
Authority
MX
Mexico
Prior art keywords
preventive
oral
inflammatory disease
cavity mucosa
remedial agent
Prior art date
Application number
MXPA03009484A
Other languages
English (en)
Inventor
Yasuhiko Kimoto
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of MXPA03009484A publication Critical patent/MXPA03009484A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA03009484A 2001-04-17 2002-04-11 Agente preventivo/de remedio para enfermedades inflamatorias en la mucosa de la cavidad oral y lo similar. MXPA03009484A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001118113 2001-04-17
PCT/JP2002/003589 WO2002085347A1 (fr) 2001-04-17 2002-04-11 Agent prophylactique/therapeutique pour les maladies inflammatoires des muqueuses de la cavite buccale et autres

Publications (1)

Publication Number Publication Date
MXPA03009484A true MXPA03009484A (es) 2004-02-12

Family

ID=18968549

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03009484A MXPA03009484A (es) 2001-04-17 2002-04-11 Agente preventivo/de remedio para enfermedades inflamatorias en la mucosa de la cavidad oral y lo similar.

Country Status (9)

Country Link
US (1) US20040132815A1 (es)
EP (1) EP1380294A1 (es)
KR (1) KR20030092073A (es)
CN (1) CN1700914A (es)
AU (1) AU2002248004B2 (es)
CA (1) CA2443944A1 (es)
MX (1) MXPA03009484A (es)
NZ (1) NZ528937A (es)
WO (1) WO2002085347A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3023718B1 (fr) * 2014-07-16 2018-10-12 Pierre Fabre Medicament Compositions pharmaceutique et/ou cosmetique decontaminees par haute pression
WO2020085356A1 (ja) * 2018-10-24 2020-04-30 サンスター株式会社 口腔用組成物
CN109608357B (zh) * 2019-01-08 2019-10-29 牡丹江医学院 一种治疗口腔炎的药物化合物和组合物及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2207890A (en) * 1938-09-29 1940-07-16 Hercules Powder Co Ltd Composition of matter and method of producing
DK172690B1 (da) * 1981-10-22 1999-05-31 Tanabe Seiyaku Co Analogifremgangsmåde til fremstilling af salte af sulfodehydroabietinsyre eller hydrater deraf
GB2122893B (en) * 1982-06-30 1985-06-26 Biorex Laboratories Ltd Glycyrrhetinic acid compositions
ATE46265T1 (de) * 1985-01-23 1989-09-15 Asta Pharma Ag Synergistische kombination von flupirtin und nicht-steroidalen antiphlogistika.
US5739107A (en) * 1991-03-11 1998-04-14 Creative Biomolecules, Inc. Morphogen treatment of gastrointestinal ulcers
JP3284206B2 (ja) * 1993-04-23 2002-05-20 サントリー株式会社 アズロイルアミノ酸誘導体
JPH10139660A (ja) * 1996-11-14 1998-05-26 Tanpei Seiyaku Kk 水溶性アズレン製剤及びその製造法
US5981499A (en) * 1998-02-20 1999-11-09 Atlantic Biomed Corporation Lesion-directed antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa
JP3587247B2 (ja) * 1999-11-11 2004-11-10 田辺製薬株式会社 炎症性腸疾患の予防・治療剤
TW585762B (en) * 1999-11-11 2004-05-01 Tanabe Seiyaku Co Pharmaceutical composition for prophylaxis or treatment of inflammatory bowel diseases
US20040057908A1 (en) * 2001-12-13 2004-03-25 Bowen William H. Oral compositions and use thereof

Also Published As

Publication number Publication date
KR20030092073A (ko) 2003-12-03
AU2002248004B2 (en) 2006-04-13
US20040132815A1 (en) 2004-07-08
NZ528937A (en) 2005-04-29
CN1700914A (zh) 2005-11-23
WO2002085347A1 (fr) 2002-10-31
CA2443944A1 (en) 2002-10-31
EP1380294A1 (en) 2004-01-14

Similar Documents

Publication Publication Date Title
IL155093A0 (en) Morpholin-acetamide derivatives for the treatment on inflammatory diseases
MXPA03008497A (es) Composiciones y kits para el cuidado oral.
HK1047968B (zh) 滾柱軸承和裝有滾柱軸承的滾子鏈
NO20034159L (no) Östrogen-gestagen-kombinasjonspreparat og anvendelse derav
MXPA03004932A (es) 2-anilino-bencimidazoles sustituidos y su uso como inhibidores de nhe.
MXPA03004459A (es) Inhibidores de imidazol y benzimidazol caspasa y usos de los mismos.
GB0116074D0 (en) Nanoparticle structures
HUP0401756A3 (en) Substituted benzimidazole compounds and their use
IL153260A0 (en) Direct drive valve ball drive mechanism and method for manufacturing the same
GB2362429B (en) Spherical bearing and method for manufacturing the same
IS7275A (is) Samsetning fyrir hollegg og notkun á henni
AU2001234585A8 (en) Ultrasonic monitor
ZA200206252B (en) Method and compositions for treating an inflammatory disease.
MXPA03009484A (es) Agente preventivo/de remedio para enfermedades inflamatorias en la mucosa de la cavidad oral y lo similar.
MXPA03004025A (es) Viscoelasticos transitorios no aspirantes para su uso en cirugia.
GB0120009D0 (en) Cause and effect diagnosis
GB0122731D0 (en) Anti-inflammatory agent
GB0004714D0 (en) The joy ball
ZA200300055B (en) Anthelminthic agents for the prevention of parasitic infections in humans and animals II.
IL146655A0 (en) The use of leptin in fertility
GB0106987D0 (en) Immunotherapeuitic agent
GB0122162D0 (en) Agent
HU0102164D0 (en) Suppository for antiinfective use in the vagina
EP1386919A4 (en) REMEDIES
AU2001100356A4 (en) Heat reduction in railway lines